Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


四月 13, 2020

Revised Drug Administration Law of the People’s Republic of China

The Standing Committee of the National People’s Congress in China passed the revised Drug Administration Law (Revised Law) on 26-Aug-19. Effective 1-Dec-19, it is the first overhaul since 2001. The Revised Law addresses the major issues in the pharmaceutical industry, demonstrating the government’s efforts in strengthening supervision to ensure drug safety.
Lynn Yao

Lynn Yao

Manager, Scientific Affairs, China

By Your Side for Expertise

三月 04, 2020

By Your Side for Industry and Regulatory Trends

Page McAndrew

T. Page McAndrew, Ph.D.

Director, Scientific Communications

By Your Side for Innovation

二月 19, 2020

West’s Commitment to Innovation Helps Customers Respond to Key Healthcare Market Trends

CIndy Reiss-Clark

Cindy Reiss-Clark

Sr. VP, Commercial Markets & Commercial Solutions

Gamma Sterilization

十月 21, 2019

Gamma Sterilization Process DMFs Harmonized

Janet Gaboury

Janet Gaboury, PhD

Sr. Specialist Regulatory Affairs

Regulatory Check List

七月 01, 2019

European Medicines Agency's (EMA) Strategy on Engaging with Regulatory Science

Bettine Boltres

Bettine Boltres, Ph.D.

Principal, Scientific Affairs, Packaging & Delivery Systems

CPhI China Tradeshow

六月 20, 2019

West Helps Simplify the Journey™ in China

Jessie Zhang

Jessie Zhang

Manager, Global Communications, AP

Particle Analysis

六月 11, 2019

Particulate Challenges

Fran DeGrazio

Fran DeGrazio

V.P. Technical Customer Service & Scientific Affairs

A nurse extracting a medication from a vial into a syringe

六月 04, 2019

Are You Ready? Compliance with New USP Chapters <381>, <382>, <1381> and <1382>

Daniel Bantz

Daniel Bantz

Technical Manager, Packaging & Performance, Laboratory

Load more